Spectrum of findings and usefulness of integrated PET/CT in patients with known or suspected neuroendocrine tumors of the lung

Positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose (FDG) has been known to increase diagnostic accuracy in differentiating benign and malignant lung lesions and to improve identification of lymph node and extrathoracic metastasis in pulmonary neoplasms. In this review, the author...

Descripción completa

Detalles Bibliográficos
Autores principales: Chong, Semin, Lee, Kyung Soo
Formato: Texto
Lenguaje:English
Publicado: e-Med 2007
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151326/
https://www.ncbi.nlm.nih.gov/pubmed/18055292
http://dx.doi.org/10.1102/1470-7330.2007.0028
_version_ 1782144722357190656
author Chong, Semin
Lee, Kyung Soo
author_facet Chong, Semin
Lee, Kyung Soo
author_sort Chong, Semin
collection PubMed
description Positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose (FDG) has been known to increase diagnostic accuracy in differentiating benign and malignant lung lesions and to improve identification of lymph node and extrathoracic metastasis in pulmonary neoplasms. In this review, the authors describe the spectrum of integrated PET/CT findings on neuroendocrine (NE) tumors of the lung. We also demonstrate the usefulness of this imaging modality in patients with known or suspected NE tumors of the lung.
format Text
id pubmed-2151326
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher e-Med
record_format MEDLINE/PubMed
spelling pubmed-21513262009-11-26 Spectrum of findings and usefulness of integrated PET/CT in patients with known or suspected neuroendocrine tumors of the lung Chong, Semin Lee, Kyung Soo Cancer Imaging Article Positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose (FDG) has been known to increase diagnostic accuracy in differentiating benign and malignant lung lesions and to improve identification of lymph node and extrathoracic metastasis in pulmonary neoplasms. In this review, the authors describe the spectrum of integrated PET/CT findings on neuroendocrine (NE) tumors of the lung. We also demonstrate the usefulness of this imaging modality in patients with known or suspected NE tumors of the lung. e-Med 2007-11-26 /pmc/articles/PMC2151326/ /pubmed/18055292 http://dx.doi.org/10.1102/1470-7330.2007.0028 Text en © 2007 International Cancer Imaging Society
spellingShingle Article
Chong, Semin
Lee, Kyung Soo
Spectrum of findings and usefulness of integrated PET/CT in patients with known or suspected neuroendocrine tumors of the lung
title Spectrum of findings and usefulness of integrated PET/CT in patients with known or suspected neuroendocrine tumors of the lung
title_full Spectrum of findings and usefulness of integrated PET/CT in patients with known or suspected neuroendocrine tumors of the lung
title_fullStr Spectrum of findings and usefulness of integrated PET/CT in patients with known or suspected neuroendocrine tumors of the lung
title_full_unstemmed Spectrum of findings and usefulness of integrated PET/CT in patients with known or suspected neuroendocrine tumors of the lung
title_short Spectrum of findings and usefulness of integrated PET/CT in patients with known or suspected neuroendocrine tumors of the lung
title_sort spectrum of findings and usefulness of integrated pet/ct in patients with known or suspected neuroendocrine tumors of the lung
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151326/
https://www.ncbi.nlm.nih.gov/pubmed/18055292
http://dx.doi.org/10.1102/1470-7330.2007.0028
work_keys_str_mv AT chongsemin spectrumoffindingsandusefulnessofintegratedpetctinpatientswithknownorsuspectedneuroendocrinetumorsofthelung
AT leekyungsoo spectrumoffindingsandusefulnessofintegratedpetctinpatientswithknownorsuspectedneuroendocrinetumorsofthelung

Ejemplares similares